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Fig. 1. A, Computed tomographic section of chest showing round mass in body of sternum. B, 
Longitudinal section of magnetic resonance image of chest showing mass located in lower part of sternal 
body and invading sternal cortex. 
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The neonatal pulmonary vasculature may be extremely 
labile. Remodeling of the vessel wall, functional maturation 
of the endothelial cell, differentiation f the smooth muscle 
cell, release of vasoactive mediators, and vessel recruitment 
all contribute to the successful transition to a mature pulmo- 
nary circulation. 1 In the child with pulmonary hypertensive 
congenital heart disease postnatal remodeling is abnormal. 2 
Even if a neonatal cardiac operation is undertaken, endo- 
thelium-dependent pulmonary vascular elaxation may be 
impaired after cardiopulmonary bypass and the postopera- 
tive course may be complicated by transient pulmonary 
hypertension. 3 
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Table I 
Patient Sex Age (days) Diagnosis Operation Response to NO 
1 M 1 Obstructed infradiaphragmatic TAPVC Repair Yes 
2 F 1 Obstructed infradiaphragmatic TAPVC Repair Yes 
3 M 2 Obstructed infradiaphragmatic TAPVC Repair Yes 
4 F 11 Obstructed infradiaphragmatic TAPVC Repair Yes 
5 M 4 D-TGA/VSD/CA ASO Yes 
6 M 5 IAA/VSD Repair Yes 
7 M 52 D-TGA/VSD/CA ASO No 
8 M 23 Truncus arteriosus type IIA Repair No 
9 M 4 D-TGA ASO Yes 
10 M 30 D-TGA/VSD/sub-PS ASO Yes 
11 F 1 Heterotaxy/unbalanced AVC, PA with BT shunt 
obstructed infradiaphragmatic TAPVC Repair TAPVC No 
12 M 15 HLHS Stage I Yes 
13 M 31 HLHS Stage I No 
14 F 43 DILV/NRG/aberrant RSCA/sub-AS Stage I No 
15 M 25 HLHS Stage I No 
NO, Inhaled nitric oxide; M, male; TAPVC, total anomalous pulmonary venous connection; F, female; D-TGA, D-transposition of the great arteries; VSD, 
ventricular septal defect; CA, coronary artery anomaly; ASO, arterial switch operation;/AA, interrupted aortic arch; sub-PS, subpulmonary stenosis; AVC, 
atrioventricular c nal defect; PA, pulmonary atresia; BT, modified Blalock-Taussig hunt; HLHS, hypoplastic left heart syndrome; stage 1, stage 1Norwood 
operation; DILV, double-inlet ft ventricle; NRG, normally related great arteries; RSCA, right subclavian rtery; Sub-AS, subaortic stenosis. 
Inhaled nitric oxide has been demonstrated to provide 
safe selective pulmonary vasodilation after cardiac oper- 
ations.4, 5However, pulmonary vasospasm is not the only 
cause of elevated proximal pulmonary artery pressures. 
After operation in the neonate with complex congenital 
heart disease it may be difficult to differentiate between 
pulmonary vasoconstriction a d anatomic obstruction to 
pulmonary blood flow. A definitive diagnosis may require 
transport of a sick newborn infant and invasive investiga- 
tion of the condition. 
Therefore we investigated the use of a trial of inhaled 
nitric oxide after operation in the neonate with pulmonary 
hypertension or excessive cyanosis to differentiate vaso- 
spasm from fixed anatomic obstruction to pulmonary 
blood flow. 
Methods. Fifteen patients with a median age of 11 days 
(range 1 to 52 days) with pulmonary hypertension (de- 
fined as a mean pulmonary artery pressure >25 mm Hg) 
or with excessive cyanosis compatible with an elevated 
pulmonary vascular resistance after cardiac operation 
underwent challenge with nitric oxide. The characteristics 
of the patients are summarized in Table I. 
All patients were studied after operation while para- 
lyzed and heavily sedated and with the lungs hyperventi- 
lated (mean pH 7.45 -+ 0.03, arterial carbon dioxide 
tension 37 -+ 2 mm Hg). In 10 patients who underwent 
biventricular repair residual left-to-right shunting was 
excluded by right atrial and pulmonary artery oximetry 
and confirmed echocardiographically. Cardiac index was 
measured by thermodilution i  eight patients and by the 
Fick method with measured oxygen saturation levels and 
measured oxygen consumption i  two. All 10 patients had 
intraoperatively placed pulmonary artery lines. Hemody- 
namic variables and oxygen saturation valves were mea- 
sured at baseline and after a 15-minute inhalation of nitric 
oxide at a dose of 80 ppm. In addition, five patients with 
excessive hypoxemia fter palliation with modified Bla- 
lock-Taussig shunts were studied. Systemic arterial oxy- 
genation was assumed to reflect pulmonary blood flow. 
Accordingly systemic blood pressure, atrial pressure, and 
systemic arterial blood gas analysis findings were recorded 
before and after 15 minutes of nitric oxide inhalation. The 
details of nitric oxide gas preparation and delivery and 
monitoring of nitrogen dioxide and methemoglobin levels 
have been reported. 3 
The Wilcoxon signed rank test was used to compare the 
change in hemodynamic parameters with nitric oxide. Values 
are expressed as mean plus or minus standard error. 
The study was approved by the investigational review 
board. Written and informed consent was obtained from 
the parents. 
Results. Nine of 15 patients howed a response with a 
fall in pulmonary artery pressure or a rise in systemic 
arterial oxygen saturation after an inhaled nitric oxide 
challenge. Six patients did not respond and all were found 
to have anatomic obstruction to pulmonary blood flow. 
Eight of 10 patients who had undergone complete 
neonatal repair showed a response to inhaled nitric oxide 
with a significant fall in mean pulmonary artery pressure 
from 35 -+ 4 to 26 -+ 4 mm Hg (p < 0.05) and in 
pulmonary vascular resistance from 17 _+ 6 to 10 _+ 4 Um z 
(p < 0.05). There was no clinically important change in 
other hemodynamic parameters. Only one of five patients 
with single ventricle and severe hypoxemia fter initial 
palliative systemic-to-pulmonary artery shunt procedures 
responded with an immediate increase in systemic arterial 
oxygen tension from 19 to 45 mm Hg. He was treated with 
continuous low-dose nitric oxide therapy until resolution 
of pulmonary vasoconstriction ccurred. 
Two patients (Nos. 7 and 8) with proximal pulmonary 
artery hypertension (both had undergone right ventricular 
outflow tract reconstruction) showed no response to in- 
haled nitric oxide. Further investigation revealed an un- 
obstructed proximal pulmonary anastomosis but hypo- 
plastic branch pulmonary arteries with low distal 
pulmonary pressures (Fig. 1). Both patients were treated 
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Fig. 1. Angiogram from patient No. 8, who had high 
proximal pulmonary artery pressures with no response to 
nitric oxide after repair of truncus arteriosus, demon- 
strates tenosis at origin of both branch pulmonary arter- 
ies distal to anastomosis with homograft. In addition, 
distal pulmonary arteries are small. 
conservatively with subsequent successful balloon dilation 
of the branch pulmonary arteries. In four of five neonates 
with refractory cyanosis after receiving modified Blalock- 
Taussig shunts, systemic arterial oxygen saturation did not 
improve sufficiently (43% -+ 11% before nitric oxide and 
51% _+ 8% with nitric oxide) in response to nitric oxide. 
All four subsequently were found to have stenotic system- 
ic-to-pulmonary artery shunts. The shunts were revised in 
all with improvement in oxygenation and three of four 
have undergone subsequent operation with fenestrated 
total cavopulmonary anastomoses. 
Discussion. In nine newborn patients with elevated 
pulmonary vascular resistance, inhaled nitric oxide re- 
duced the pulmonary artery pressure and pulmonary 
vascular resistance selectively without adverse systemic 
effects, thus confirming pulmonary vasoconstriction as the 
cause of increased right ventricular afterload. However, in 
six patient s with proximal pulmonary artery hypertension 
or refractory cyanosis, a postoperative challenge with 
inhaled nitric oxide failed to reduce pulmonary artery 
pressure or improve systemic oxygenation. All six patients 
were found to have anatomic obstruction to pulmonary 
blood flow. Thus the judicious use of a trial of inhaled 
nitric oxide may be of value to rule out pulmonary 
vasoconstriction a d direct investigation toward reassess- 
ment of the surgical result. 
Certain young children with transposition of the great 
arteries, truncus arteriosus, and single ventricle have 
labile pulmonary vascular beds with pulmonary vasocon- 
striction and hypertension. However, high proximal pul- 
monary artery pressures alternatively may indicate distal 
pulmonary artery stenosis. In patients with single ventri- 
cle, intense cyanosis after insertion of a Blalock-Taussig 
shunt may reflect systemic-to-pulmonary tery shunt 
obstruction. We do not propose that a trial of inhaled 
nitric oxide should replace or delay diagnostic procedures 
when anatomic obstruction to pulmonary flow is evident. 
However, in neonatal cases when there is genuine doubt, 
failure of the patient o show a response to nitric oxide 
should be regarded as strong evidence of anatomic and 
possibly surgically remediable obstruction. 
We have reported here the use of a short challenge with 
inhaled nitric oxide after operation in the neonate with 
congenital heart disease and proxima ! pulmonary artery 
hypertension or excessive cyanosis. We have described 
how the results of such a challenge may be used advanta- 
geously to direct therapy in the patient with pulmonary 
vasoconstriction who shows response to nitric oxide or in 
the patient who shows no response with further investiga- 
tion of surgically remediable obstruction to pulmonary 
blood flow. 
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